Tumor Board - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Tumor Board

Description:

68 y/o AA M who presented to Sinai ER with a 7 day history of severe rectal pain ... Admit IVF, NPO, Bowel prep for Colonoscopy. Colonoscopy ... – PowerPoint PPT presentation

Number of Views:3441
Avg rating:3.0/5.0
Slides: 23
Provided by: lifebrid
Category:

less

Transcript and Presenter's Notes

Title: Tumor Board


1
Tumor Board
  • March 27, 2007

2
Tumor Board
  • RB
  • 68 y/o AA M who presented to Sinai ER with a 7
    day history of severe rectal pain with bright red
    bloody bowel movements
  • c/o narrowing of stool, diminished caliber of
    stools for a few months
  • chronic constipation
  • PMHx- HTN, anxiety and hemorrhoids

3
Tumor Board
  • PSHx- none
  • Meds- Lotrel, Ativan
  • SHx- Smoking
  • FHx- Noncontributory
  • Vitals- T 37.1 P-57 Bp 136/65 O2-98 RA
  • Gen- elderly gentleman lying comfortably
  • HEENT- Sclerae-nonicteric, No lymph nodes in
    cervical or axillary region

4
Tumor Board
  • Lungs- CTAB no wheezing, no rales
  • Abdomen- soft, nd, nt, bowel sounds-active, no
    shifting dullness, no rebound tenderness
  • Rectal- refused due to exquisite tenderness
  • Labs
  • H/H 11.4/35
  • other labs w/n normal limits

5
Tumor Board
  • Plan
  • Admit IVF, NPO, Bowel prep for Colonoscopy
  • Colonoscopy
  • Single friable malignant obstructing ulcerated
    whitish mass present at the ano-rectal junction
    which measured about 5 cm
  • multiple biopsies taken
  • Pathology
  • Anorectal mass- tubular adenomatous tissue with
    at least high grade dysplasia, suspicious for
    invasive malignancy

6
Tumor Board
  • Surgical Oncology consulted
  • CT showed no distant metastases
  • Biopsy- Adenocarcinoma
  • Groin lymph nodes not involved
  • Clinical Impression-Carcinoma of the rectum at
    the lower 1/3 involving the sphinchter
  • Rectal Ultrasound- shows invasion into muscle of
    sphincter

7
Tumor Board
  • BON
  • Post-Op Dx- Lower 1/3 carcinoma of the rectum
  • Procedure- APR
  • EBL-300cc
  • Drain- 1
  • Complications- none

8
Tumor Board
  • Post Operative
  • No complications
  • Awaiting Discharge

9
Sphincter Preservation in Rectal CA
  • Although optimal treatment of tumors at mid and
    distal rectum continues to be a matter of great
    debate
  • goal of sphincter preservation should be
    considered in all patients with an intact
    sphincter is preferred
  • Growing evidence and indications
  • that sphincter-preserving procedure might be a
    valid alternative to conventional modality in
    tumors of the mid or lower rectum.

10
Tumor Board
  • Traditionally, an abdominoperineal resection with
    permanent colostomy would be the sole surgical
    option.
  • Recently, a variety of sphincter-preserving
    procedures are being performed in majority of
    distal rectal cancers
  • acceptable oncologic and optimal functional
    results.
  • Several recent advances may further influence
    future treatment strategies
  • and many issues under evaluation

11
Rectal Ca
  • Criteria
  • Three conditions to be met for any restorative
    procedure
  • Excision of tumor must be adequate
  • Residual sphincter function must be satisfactory
  • Technical difficulty must be manageable

12
Rectal Ca
  • Excision of tumor
  • Most important recent discovery
  • Minimal extent of downward intramural spread of
    the tumor
  • In low or average grade tumors spread beyond 2 cm
    from the growing edge of the tumor occurs in only
    1 of patients
  • Even for anaplastic tumors, the incidence of
    travel beyond 2 cm is only 5 to 6
  • Thus adequate excision my require only 2-3 cm
    margins beyond the edge of the tumor
  • Although, the need to remove the proximal rectum
    together with the area of upward lymphatic spread
    and the pararectal tissues up the side wall of
    the pelvis wall remains unchanged

13
Rectal Cancer
  • Sphincter control depends on intact
  • Sensory
  • Preservation of anal canal and pelvic floor
    muscles
  • Motor
  • Preservation of the puborectalis sling and the
    internal and external anal sphincters

14
Rectal CA
  • Technical Feasibility
  • Transphinteric Approach
  • Short anorectal stump delivered by dividing the
    somatic component of the sphincter complex
  • Abdomen then closed
  • Anal sphincter incised vertically until gut tube
    exposed
  • Tumor is delivered and resection carried out
  • Transanal Approach
  • Anorectal stump dilated in order to insert
    special retractor
  • Tumor is resected through the abdomen
  • Cut end of left colon is then drawn into the
    pelvis and sutured to the anorectal stump within
    the lumen

15
Role of TME
  • Total Mesorectal Excision
  • The mesorectum consists of fatty tissue
    surrounding the rectum and contains the
    lymphatics that drain the rectum
  • Isolated deposits of tumor can be found within
    the mesorectum up to 3 cm distal to the main
    tumor
  • Total mesorectal excision has reduced local
    recurrence following surgery to less than 10

16
Role of TME
  • Theory
  • That the embryology of the fetal hind-gut, a
    midline structure,
  • predicates that initial cancer spread will remain
    within the mesorectum and thus be encompassed by
    the mesorectal fascia.
  • This fascia provides the surgeon with a
    "navigation system" on which the efficient
    performance of TME is based.

17
Role of tme
  • TME is the gold standard therapy in many European
    countries for middle and lower third rectal
    cancers
  • Specifically, local recurrence following TME is
    about 6.6
  • Most of the literature performed are
    restrospective studies
  • Recent studies have clarified a benefit to
    adjuvant chemotherapy with TME
  • Further literature supports that TME is a
    feasible, reproducible adjunctive surgical
    therapy in the management of Rectal CA

18
Rectal Ultrasound
  • Preoperative evaluation of rectal cancer has
    become increasingly important,
  • Allowsto identify patients
  • with locally advanced disease
  • who may benefit from neoadjuvant
    chemoradiotherapy and those suitable for local
    resection.
  • Endoscopic rectal ultrasound (ERUS)
  • accurately indicates the extent of tumour spread
    through the wall of the rectum in over 90 of
    cases (T stage) and the involvement of perirectal
    lymph nodes in up to 80 (N stage)

19
Rectal Ultrasound
  • It is an essential investigation for those being
    considered for local resection
  • Currently, examination by ERUS is limited to
    tumors within the distal rectum but the recent
    development of colonoscopic ultrasound may prove
    useful to evaluate more proximal disease

20
Rectal Ultrasound
  • Identifying Recurrence
  • Endorectal ultrasound identifies one-third of
    asymptomatic local recurrences that were missed
    by digital examination or proctoscopic
    examination

21
Rectal Ultrasound
  • Currently evidence supports use of MRI
  • The crucial advantage of MRI is not that it
    enables exact T-staging but precise evaluation of
    the topographic relationship of a tumor to the
    mesorectal fascia.
  • The fascia is the most important anatomic
    landmark for the feasibility of total mesorectal
    excision, which has evolved into the standard
    operative procedure for the resection of cancer
    located in the middle or lower third of the
    rectum.
  • MRI has been shown to illuminate the mesorectum
    well

22
Rectal Ultrasound
  • In general,
  • Effective method
  • Surpassed by some other modalities on certain
    aspects
  • Ex. MRI
Write a Comment
User Comments (0)
About PowerShow.com